Status:
COMPLETED
The Impact of Vaccination on Severity of Illness in COVID-19
Lead Sponsor:
Corewell Health East
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
With the FDA's emergency use authorization declaration in December of 2020, the Pfizer-BioNtech vaccine became the first of several vaccines to kick off the mass vaccination effort across the United S...
Detailed Description
A retrospective chart review of all patients presenting to Beaumont Health System emergency departments between December 15, 2020 and April 30, 2021 who tested positive for COVID-19 will be performed....
Eligibility Criteria
Inclusion
- All patients presenting to Beaumont Health emergency departments who have tested positive for COVID-19 between December 15, 2020 and April 30, 2021 with available vaccination data through state of Michigan registry.
Exclusion
- Patients who have previously tested positive for COVID-19 prior to the study period will be excluded.
- Patients with missing vaccine status will be excluded.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 7 2021
Estimated Enrollment :
11834 Patients enrolled
Trial Details
Trial ID
NCT04912700
Start Date
June 1 2021
End Date
June 7 2021
Last Update
September 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beaumont Hospital - Royal Oak
Royal Oak, Michigan, United States, 48073